S656 Deprescription of Aspirin for Primary Cardiovascular Prophylaxis Is Rarely Performed at Discharge in Hospitalized Patients With Gastrointestinal Bleeding

Abstract

Table 1. (continued) Unmatched cohorts Propensity matched cohorts Colonoscopy &#60aff 7 days (N 5 13,890) Colonoscopy . 7 days (N 5 103,718) Colonoscopy &#60aff 7 days (N 5 12,502) Colonoscopy . 7 days (N 5 12,502) Type 2 diabetes 2,579 (20.6%) 20,162 (20.5%) 2,579 (20.6%) 2,532 (20.5%) BMI $ 30 4,424 (35.4%) 29,734 (30.3% 4,424 (35.4%) 4,090 (32.7%) Atherosclerosis 633 (5.1%) 5,812 (5.9%) 633 (5.1%) 544 (4.4%) NSAID use 3,921 (31.4%) 29,896 (30.5%) 3,921 (31.4%) 4,017 (32.1%) Anticoagulant use 2,810 (22.5%) 21,327 (21.7%) 2,810 (22.5%) 2,792 (22.3%) Anti-platelet agent use 3,532 (28.3%) 24,942 (25.4%) 3,532 (28.3%) 3,459 (27.7%)